文献速递头颈外科

COVID-19疫情期间免疫功能受损头颈癌患者的诊疗:两例挑战性病例

Care of immunocompromised patients with head and neck cancer during the COVID-19 pandemic: Two challenging and informative clinical cases.
PubMed 文献 · Head Neck · 2020-04-22

本文通过两例新诊断头颈恶性肿瘤的免疫功能受损患者,探讨COVID-19疫情期间头颈肿瘤医生如何在肿瘤进展风险与病毒感染风险之间进行平衡。两例患者最终采取了不同的诊疗策略,作者指出对该异质性群体无统一规则,并提供了若干一般性原则以指导临床管理。

要点

  • 免疫功能受损头颈癌患者需平衡肿瘤进展与COVID-19感染风险。
  • 两例类似患者最终采取不同诊疗策略,提示需个体化决策。
  • 对该异质性群体无统一规则,可参考一般性原则指导管理。

核心结论

  • 对免疫功能受损的头颈癌患者不存在统一的规则,需个体化决策。
  • 作者提供了一些一般性原则以帮助疫情期间的患者管理。

研究设计与样本

  • 通过两例新诊断头颈恶性肿瘤的免疫功能受损患者进行病例分析。

主要发现

  • 经过仔细考虑各种选择后,两例患者采取了不同的诊疗方式。

临床怎么用

  • 头颈肿瘤医生应综合评估肿瘤进展风险与患者/医务人员暴露于病毒感染的风险。
  • 对免疫功能受损患者需个体化咨询与管理,参考一般性原则。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND METHODS: There is an added level of complexity in the management of head and neck cancer patients with underlying immunosuppressive disorders during the COVID-19 pandemic. Head and neck oncologists are tasked with balancing the dual risks of cancer progression in the setting of impaired tumor immunity and increased susceptibility to life-threatening complications from exposure to viral infection for patients and providers. Through two cases of immunocompromised patients with newly diagnosed head and neck malignancies, we aim to provide guidance to clinicians struggling with how to best counsel and manage this unique subset of patients under these difficult circumstances. RESULTS: After careful consideration of the options, we took different approaches in the care of these two patients. CONCLUSIONS: Ultimately, there is no uniform set of rules to apply to this heterogeneous group of immunocompromised patients. We provide some general principles to help guide patient management during the current pandemic.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Civantos AM, Carey RM, Lichtenstein GR, et al. Care of immunocompromised patients with head and neck cancer during the COVID-19 pandemic: Two challenging and informative clinical cases. Head Neck. 2020. PMID: 32298006. doi:10.1002/hed.26165

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。